Dana-Farber Cancer Institute: Breast Neoplasms trials

The registry lists 134 Breast Neoplasms studies with Dana-Farber Cancer Institute as lead sponsor. 15 are open to participants now and 54 have results posted.

Early Phase 1 2Phase 1 21Phase 2 59Phase 3 2No phase 54(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Novel Social Media Intervention For Older Br CA PatientsCompletedNCT02639208Not applicable
• Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving TherapyCompletedNCT02335671Not applicable
• A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer PatientsCompletedNCT02129686Not applicable
• Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)CompletedNCT02057432Not applicable
• RPFNA Assessment of Exercise Effect in Breast CancerCompletedNCT01961128Not applicable
• ARRY-380 + Trastuzuamab for Breast w/ Brain MetsCompletedNCT01921335Phase 1
• Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative ChemotherapyCompletedNCT01894451Early Phase 1
• Cisplatin + RT for Triple Negative Breast CancerCompletedNCT01674842Phase 1
• Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast CancerCompletedNCT01647607Not applicable
• Pilot Study for Young Women's InterventionCompletedNCT01647594Not applicable
• Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian CancerCompletedNCT01623349Phase 1
• Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision LumpectomyTerminatedNCT01568346Phase 3
• The Preoperative Health & Body StudyActive, not recruitingNCT01516190Not applicable
• The Young Women's Breast Cancer StudyActive, not recruitingNCT01468246
• Hypertension in Breast Cancer Patients Receiving BevacizumabTerminatedNCT00674011
• The Active After Cancer Trial (AACT)Active, not recruitingNCT00548236Not applicable
• ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast CancerCompletedNCT00496665Phase 1
• Exercise Intervention in Women With Metastatic Breast CancerCompletedNCT00405782Not applicable
• Letrozole in Postmenopausal Women at Increased Risk for Breast CancerStatus unknownNCT00280930Phase 2
• Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer PatientsCompletedNCT00268918Phase 1
• High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast CarcinomaTerminatedNCT00165581Not applicable
• Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease SurvivorsCompletedNCT00165308Not applicable
• Tangential Radiation Therapy Without Axillary Dissection in Breast CancerCompletedNCT00165243Phase 2
• Navelbine and Capecitabine in the Treatment of Metastatic Breast CancerCompletedNCT00153907Phase 1
• Effects of Exercise Intervention on Insulin Levels in Breast Cancer SurvivorsCompletedNCT00153894Not applicable
• Capecitabine in Women With Operable Breast CancerTerminatedNCT00148720Phase 2
• Study of Xyotax (CT-2103) in Patients With Metastatic Breast CancerCompletedNCT00148707Phase 2
• Preoperative Cisplatin in Early Stage Breast CancerCompletedNCT00148694Phase 2
• Preoperative Herceptin and Navelbine for Breast CancerCompletedNCT00148681Phase 2
• Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast CancerCompletedNCT00146601Phase 2
• Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast CancerCompletedNCT00146549Phase 3
• Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional BiopsyCompletedNCT00146536
• Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast CancerCompletedNCT00083031Phase 2
• Vaccine Therapy in Treating Patients With Metastatic Breast CancerCompletedNCT00003761Phase 1